kala azar

Visceral leishmaniasis (VL), also known as kala azar, is a worldwide protozoal vector-borne disease, endemic in 76 countries. The annual incidence is estimated to be 250-300,000 cases, with over 90...

Briefing – Last updated 15 March 2012
www.msfaccess.org/content/combating-kala-azar-don%E2%80%99t-fail-patients

India 2011 © Anna Surinyach/MSF Barcelona, New Delhi -- Bihar state, in the northeast of India, is an epicentre of kala azar (visceral leishmaniasis), a neglected tropical disease...

Press Release – Last updated 15 March 2012
www.msfaccess.org/about-us/media-room/press-releases/msf-calls-spotlight-kala-azar

Performing a spinal tap under field conditions is nerve-wracking. Sticking a needle into someone's spine to extract spinal fluid is painful and risky and that's just the doctor's perspective....

Op-eds & Articles – Last updated 31 January 2012
www.msfaccess.org/content/what-uniting-combat-neglected-tropical-diseases-will-really-require

LONDON, 30 January 2012 –  The Gates Foundation-hosted conference held in London today, ‘Uniting To Combat Tropical Diseases’, draws attention to devastating tropical illnesses...

Press Release – Last updated 31 January 2012
www.msfaccess.org/about-us/media-room/press-releases/combating-neglected-tropical-diseases-what-still-missing

Visceral leishmaniasis (VL), a protozoan disease transmitted by sandflies, is the second-biggest parasitic killer worldwide (after malaria). In Ethiopia, the host country for the ICASA 2011 conference,...

Op-eds & Articles – Last updated 03 January 2012
www.msfaccess.org/content/msf-initial-outcomes-combination-treatment-hiv-and-visceral-leishmaniasis-co-infection

Today is the last day of the 16th International Conference on AIDS and STIs in Africa (ICASA), in Addis Ababa, Ethiopia. Ethiopia is a hotspot for cases of co-infection between HIV and visceral leishmaniasis:...

Op-eds & Articles – Last updated 08 December 2011
www.msfaccess.org/content/visceral-leishmaniasishiv-co-infection-east-africa

“This agreement is significant in that it helps address immediate treatment needs in some countries for one of the world’s most neglected diseases. But it can not be seen as a global...

Statements, Speeches, Letters – Last updated 08 December 2011
www.msfaccess.org/content/msf-statement-response-gilead-donation-ambisome-visceral-leishmaniasis

With new MSF data showing combination treatments give promising results, diagnosis and treatment of VL should be scaled up South Sudan 2010 © Olga Overbeek ADDIS ABABA/NAIROBI, 8 December...

Press Release – Last updated 09 December 2011
www.msfaccess.org/about-us/media-room/press-releases/east-african-hiv-programmes-must-wake-visceral-leishmaniasis

NAIROBI/ADDIS ABABA, Dec. 3, 2011 – As Africa’s AIDS Conference convenes in Addis Ababa tomorrow, efforts to combat HIV in sub-Sahara Africa are under serious threat because of a massive...

Press Release – Last updated 08 December 2011
www.msfaccess.org/about-us/media-room/press-releases/african-aids-conference-msf-calls-increased-funding-hiv-treatment

The interaction of visceral leishmaniasis (kala azar) with HIV/AIDS adds considerable complexity to the treatment of both diseases. Prevention of VL in people living with HIV in VL-endemic...

Briefing – Last updated 28 November 2011
www.msfaccess.org/content/double-burden-hiv-visceral-leishmaniasis-co-infection-east-africa